{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T15:31:39Z","timestamp":1784215899490,"version":"3.55.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T00:00:00Z","timestamp":1638403200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000864","name":"Michael J Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.parkreldis.2021.11.027","type":"journal-article","created":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T11:51:55Z","timestamp":1637841115000},"page":"15-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Analysis of a precision medicine approach to treating Parkinson's disease: Analysis of the DATATOP study"],"prefix":"10.1016","volume":"94","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0582-5266","authenticated-orcid":false,"given":"Sid E.","family":"O'Bryant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3920-5877","authenticated-orcid":false,"given":"Melissa","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leigh","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.parkreldis.2021.11.027_bib1","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","article-title":"Epidemiology of Parkinson's disease","volume":"124","author":"Tysnes","year":"2017","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.parkreldis.2021.11.027_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/mds.20609","article-title":"Burden of illness in Parkinson's disease","author":"Huse","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2021.11.027_bib3","doi-asserted-by":"crossref","DOI":"10.1007\/s00702-011-0682-x","article-title":"Biomarker candidates of neurodegeneration in Parkinson's disease for the evaluation of disease-modifying therapeutics","author":"Gerlach","year":"2012","journal-title":"J. Neural. Transm."},{"issue":"2","key":"10.1016\/j.parkreldis.2021.11.027_bib4","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1586\/14737159.2015.1002470","article-title":"Companion diagnostics: the key to personalized medicine. Foreword","volume":"15","author":"Jorgensen","year":"2015","journal-title":"Expert Rev. Mol. Diagn"},{"key":"10.1016\/j.parkreldis.2021.11.027_bib5","doi-asserted-by":"crossref","DOI":"10.14283\/jpad.2016.112","article-title":"Precision medicine - the golden gate for detection, treatment and prevention of Alzheimer's disease","author":"Hampel","year":"2016","journal-title":"J. Prevent. Alzheimer's Dis."},{"key":"10.1016\/j.parkreldis.2021.11.027_bib6","unstructured":"Precision Medicine | FDA."},{"issue":"7","key":"10.1016\/j.parkreldis.2021.11.027_bib7","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.molmed.2015.05.003","article-title":"Clinical application of companion diagnostics","volume":"21","author":"Jorgensen","year":"2015","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.parkreldis.2021.11.027_bib8","article-title":"Cytochrome p450 gene variants, race, and mortality among clopidogrel-treated patients after acute myocardial infarction","author":"Cresci","year":"2014","journal-title":"Circulation: Cardiovascular Genetics"},{"issue":"1","key":"10.1016\/j.parkreldis.2021.11.027_bib9","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3233\/JAD-180619","article-title":"A precision medicine model for targeted NSAID therapy in Alzheimer's disease","volume":"66","author":"O'Bryant","year":"2018","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.parkreldis.2021.11.027_bib10","series-title":"BEST (Biomarkers, EndpointS, and Other Tools) Resource Glossary","year":"2016"},{"key":"10.1016\/j.parkreldis.2021.11.027_bib11","first-page":"374","article-title":"Potential two-step proteomic signature for Parkinson's disease: pilot analysis in the Harvard Biomarkers Study","volume":"11","author":"O'Bryant","year":"2019","journal-title":"Alzheimer's Dementia: Diagn. Assess. Dis. Monit."},{"key":"10.1016\/j.parkreldis.2021.11.027_bib12","doi-asserted-by":"crossref","DOI":"10.1007\/s00702-011-0653-2","article-title":"Parkinson's disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structures","author":"Hakimi","year":"2011","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.parkreldis.2021.11.027_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109042","article-title":"Network analysis identifies SOD2 mRNA as a potential biomarker for Parkinson's disease","author":"Santiago","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.parkreldis.2021.11.027_bib14","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddg357","article-title":"Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease","author":"Li","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.parkreldis.2021.11.027_bib15","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-017-0158-z","article-title":"Defining the contribution of neuroinflammation to Parkinson's disease in humanized immune system mice","author":"Manocha","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.parkreldis.2021.11.027_bib16","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2018.0345","article-title":"Discovering new benefits fromold drugs with big data-promise for Parkinson disease","author":"Olsen","year":"2018","journal-title":"JAMA Neurology"},{"key":"10.1016\/j.parkreldis.2021.11.027_bib17","article-title":"Targeting the noradrenergic system for anti-inflammatory and neuroprotective effects: implications for Parkinson's disease","author":"O\u2032neill","year":"2018","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.parkreldis.2021.11.027_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2018.05.002","article-title":"Niacin modulates macrophage polarization in Parkinson's disease","author":"Wakade","year":"2018","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.parkreldis.2021.11.027_bib19","article-title":"Preclinical study of ibuprofen loaded transnasal mucoadhesive microemulsion for neuroprotective effect in MPTP mice model","author":"Mandal","year":"2018","journal-title":"Iran. J. Pharm. Res. (IJPR)"},{"key":"10.1016\/j.parkreldis.2021.11.027_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/jnr.24185","article-title":"Updates on immunity and inflammation in Parkinson disease pathology","author":"Joshi","year":"2018","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.parkreldis.2021.11.027_bib21","series-title":"The Effects of Probiotic Supplementation on Gene Expression Related to Inflammation, Insulin and Lipid in Patients with Parkinson's Disease: A Randomized, Double-Blind, Placebo-Controlled Trial","author":"Borzabadi","year":"2018"},{"key":"10.1016\/j.parkreldis.2021.11.027_bib22","series-title":"The Effects of Probiotic Supplementation on Gene Expression Related to Inflammation, Insulin and Lipid in Patients with Parkinson's Disease: A Randomized, Double-Blind, Placebo-Controlled Trial","author":"Borzabadi","year":"2018"},{"key":"10.1016\/j.parkreldis.2021.11.027_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacl.2015.12.017","article-title":"A randomized-controlled clinical trial investigating the effect of omega-3 fatty acids and Vitamin E co-supplementation on markers of insulin metabolism and lipid profiles in gestational diabetes","author":"Taghizadeh","year":"2016","journal-title":"J. Clin. Lipidol."},{"issue":"3 Suppl 1","key":"10.1016\/j.parkreldis.2021.11.027_bib24","first-page":"S160","article-title":"A decade of neuroprotective inquiry. Parkinson study group. Deprenyl and tocopherol antioxidative therapy of parkinsonism","volume":"44","author":"Shoulson","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.parkreldis.2021.11.027_bib25","article-title":"A multicenter controlled clinical trial in early Parkinson's disease: Parkinson study group","author":"Datatop","year":"1989","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.parkreldis.2021.11.027_bib26","article-title":"Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP patients requiring levodopa","author":"Penney","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.parkreldis.2021.11.027_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2014.12.027","article-title":"CSF tau and tau\/A\u03b242 predict cognitive decline in Parkinson's disease","author":"Liu","year":"2015","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2021.11.027_bib28","article-title":"Serum cholesterol and the progression of Parkinson's disease: results from DATATOP","author":"Huang","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.parkreldis.2021.11.027_bib29","doi-asserted-by":"crossref","DOI":"10.1001\/archneurol.2009.295","article-title":"The clinically important difference on the unified Parkinson's disease rating scale","author":"Shulman","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.parkreldis.2021.11.027_bib30","doi-asserted-by":"crossref","DOI":"10.1001\/archneurol.2009.295","article-title":"The clinically important difference on the unified Parkinson's disease rating scale","author":"Shulman","year":"2010","journal-title":"Arch. Neurol."},{"issue":"4","key":"10.1016\/j.parkreldis.2021.11.027_bib31","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.3233\/JAD-141041","article-title":"Validation of a serum screen for Alzheimer's disease across assay platforms, species, and tissues","volume":"42","author":"O'Bryant","year":"2014","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.parkreldis.2021.11.027_bib32","first-page":"83","article-title":"A blood screening test for Alzheimer's disease","volume":"3","author":"O'Bryant","year":"2016","journal-title":"Alzheimer's Dementia: Diagn. Assess. Dis. Monit."},{"key":"10.1016\/j.parkreldis.2021.11.027_bib33","doi-asserted-by":"crossref","DOI":"10.1001\/jama.289.21.2819","article-title":"Effects of rofecoxib or naproxen vs placebo on alzheimer disease progression: a randomized controlled trial","author":"Aisen","year":"2003","journal-title":"J. Am. Med. Assoc."},{"issue":"1","key":"10.1016\/j.parkreldis.2021.11.027_bib34","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/2047-9158-2-19","article-title":"Monoamine oxidase-B (MAO-B) inhibitors: implications for disease-modification in Parkinson's disease","volume":"2","author":"Teo","year":"2013","journal-title":"Transl. Neurodegener."},{"issue":"23","key":"10.1016\/j.parkreldis.2021.11.027_bib35","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1016\/S0024-3205(03)00174-7","article-title":"A pharmacological analysis elucidating why, in contrast to (-)-deprenyl (selegiline), alpha-tocopherol was ineffective in the DATATOP study","volume":"72","author":"Miklya","year":"2003","journal-title":"Life Sci."},{"key":"10.1016\/j.parkreldis.2021.11.027_bib36","unstructured":"Applications Covered by Section 505(b)(2) | FDA."}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135380202100434X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135380202100434X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:23:51Z","timestamp":1761179031000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S135380202100434X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":36,"alternative-id":["S135380202100434X"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2021.11.027","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of a precision medicine approach to treating Parkinson's disease: Analysis of the DATATOP study","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2021.11.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}